Bluebird Bio Inc. buy Bank of America Co.
Start price
21.12.23
/
50%
€1.25
Target price
21.12.24
€4.55
Performance (%)
-30.14%
Price
26.04.24
€0.87
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ for Bluebird Bio Inc. is performing very badly with a performance of -30.14%. This prediction currently runs until 21.12.24. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bluebird Bio Inc. | -8.293% | -8.293% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Bank of America Co. from $12.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for BLUE provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Bluebird Bio Inc.
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€2.87
11.12.23
11.12.23
€11.15
11.12.24
11.12.24
-69.56%
26.04.24
26.04.24
